Kristin Meliambro, MD
img_Kristin Meliambro
ASSOCIATE PROFESSOR | Medicine, Nephrology
Are you a patient?
Specialties
Nephrology

MD, Icahn School of Medicine at Mount Sinai

Residency, Internal Medicine, Mount Sinai Hospital

Fellowship, Nephrology, Mount Sinai Hospital

Publications

Selected Publications

Podocyte-derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosis. Liping Yu, Ubong S. Ekperikpe, Hunter W. Korsmo, Serena Zhao, Zhengzi Yi, Jonathan Haydak, Sean Lefferts, Kristin Meliambro, Kirk N. Campbell, Evren U. Azeloglu, Donald E. Kohan, Phillip J. McCown, Abhijit S. Naik, Edgar A. Otto, Börje Haraldsson, Weijia Zhang, Ilse S. Daehn. Kidney International

Liquid Biopsy-Multiomics Link Adhesion Pathway Dysregulation to Kidney Injury Severity. Nanditha Anandakrishnan, Zhengzi Yi, Zeguo Sun, Tong Liu, Jonathan Haydak, Sean Eddy, Pushkala Jayaraman, Stefanie DeFronzo, Aparna Saha, Qian Sun, Dai Yang, Anthony Mendoza, Gohar Mosoyan, Huei Hsun Wen, Jia Fu, Thomas Kehrer, Rajasree Menon, Edgar A. Otto, Bradley Godfrey, Joanna Yang, Mayte Suarez-Farinas, Sean Leffters, Akosua Twumasi, Kristin Meliambro, Alexander W. Charney, Adolfo García-Sastre, Kirk N. Campbell, G. Luca Gusella, John Cijiang He, Lisa Miorin, Girish N. Nadkarni, Juan Wisnivesky, Hong Li, Matthias Kretzler, Steve G. Coca, Lili Chan, Weijia Zhang, Evren U. Azeloglu. Kidney International Reports

Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans. Xiaolin He, Estefania Rodriguez Ballestas, Li Zeng, Tianzhou Zhang, Caitriona M. McEvoy, Paraish S. Misra, Victoria Ki, Arnold Apostol, Jenny S. Wong, Kristin Meliambro, Justina Ray, Marina De Cos, Maria Elena Melica, Paola Romagnani, Ye Feng, Adriana Krizova, Ira How, Ivy A. Rosales, Robert B. Colvin, John Cijiang He, Kirk N. Campbell, Darren A. Yuen. Science Translational Medicine

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Meliambro during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • George Clinical

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.